Insulin and IGF-I receptors signaling in protection from apoptosis

Hormone and Metabolic Research

Volumn 31, Issue 2-3, 1999, Pages 80-89

  Prisco, M ^a   Romano, G ^a   Peruzzi, F ^a   Valentinis, B ^a   Baserga, Renato ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

IGF I, insulin like growth factor; IGF IR, IGF I receptor; IR, insulin receptor; IRS, insulin receptor substrate; MEF, mouse embryo fibroblasts; PI 3 ki, phosphatidylinositol 3' kinase; SFM, serum free medium; Y, tyrosine residue

Indexed keywords

INSULIN; INSULIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR; SOMATOMEDIN RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; FIBROBLAST; GENETIC TRANSFECTION; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0032923859     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978703     Document Type: Article

References (64)

1. 1. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochem Biophys Acta 1997; 1332: 105-26
2. 2. O'Connor R, Kauffmann-Zeh a, Liu Y, Lehar S, Evan G, Baserga R, Blättler W. Identification of domains of the insulin-like growth factor 1 receptor that are required for protection from apoptosis. Mol Cell Biol 1997; 17: 427-35
3. 3. D'Ambrosio C, Valentinis B, Prisco M, Reiss K, Rubini M, Baserga R. Protective effect of the IGF-I receptor on apoptosis induced by okadaic acid. Cancer Res 1997; 57: 3264-71
4. 4. Myers MJ, Sun XJ, Cheatham B, Jachna BR, Glasheen EM, Backer JM, White MF. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinol 1993; 132: 1421-30
5. 5. Pronk GJ, McGlade J, Pelicci G, PawsonT, Bos JL. Insulin-induced phosphorylation of the 46-and 52-kDa Shc proteins. J Biol Chem 1993; 268: 5748-53
6. 6. Yamauchi K, Pessin JE. Enhancement or inhibition of insulin signaling by insulin receptor substrate 1 is cell context dependent. Mol Cell Biol 1994; 14: 4427-34
7. 7. Gustafson TA, He W, Craparo A, Schaub CD, O'Neill TJ. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol Cell Biol 1995; 15: 2500-8
8. 8. Tartare-Deckert S, Sawka-Verhelle D, Murdaca J, Van Obberghen E. Evidence for a differential interaction of shc and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system. J Biol Chem 1995; 270: 23456-60
9. 9. Prisco M, Hongo A, Rizzo MG, Sacchi A, Baserga R. The IGF-I receptor as a physiological relevant target of p53 in apoptosis caused by Interleukin-3 withdrawal. Mol Cell Biol 1997; 17: 1084-92
10. 10. Zamorano J, Wang HY, Wang L-M, Pierce JH, Keegan AD. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J Immunol 1996; 157: 4926-34
11. 11. Zhou-Li F, Xu SQ, Dews M, Baserga R. Co-operation of simian virus 40T antigen and insulin receptor substrate-1 in protection from apoptosis induced by Interleukin-3 withdrawal. Oncogene 1997; 15: 961-70
12. 12. Parrizas M, Saltiel AR, LeRoith D. Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J Biol Chem 1997; 272: 154-61
13. 13. Kulik G, Klippel A, Weber MJ. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 1997; 17: 1595-1606
14. 14. Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN, Hay N. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes & Develop 1997; 11: 701-13
15. 15. Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J. Matrix adhesion and ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 1997; 16: 2783-93
16. 16. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G. Suppression of c-myc-induced apoptosis by ras signalling through PI(3)K and PKB. Nature 1997; 385: 544-8
17. 17. Merlo GR, Basolo F, Fiore L, Duboc L, Hynes NE. p53-dependent and p53-independent activation of apoptosis in mammary gland epithelial cells reveals a survival function of EGF and insulin. J Cell Biol 1995; 128: 1185-96
18. 18. Hsing AY, Kadomatsu K, Bonham NJ, Danielpour D. Regulation of apoptosis induced by transforming growth factor β1 in nontumorigenic and tumorigenic rat prostatic epithelial cell lines. Cancer Res 1996; 56: 5146-9
19. 19. Stewart CEH, Rotwein P. Insulin-like growth factor II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 1996; 271: 11330-8
20. 20. Xu F, Gardner A, Tu Y, Michl P, Prager D, Lichtenstein A. Multiple myeloma cells are protected against dexamethasone-induced apoptosis by insulin-like growth factors. Br J Haematol 1997; 97: 429-40
21. 21. Kummer JL, Ran PK, Heidenreich KA. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J Biol Chem 1997; 272: 20490-4
22. 22. Menke AL, Shvarts A, Riteco N, van Ham RCA, van der Eb AJ, Jochemsen AG. Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor. Cancer Res 1997; 57: 1353-63
23. 23. Gunn-Moore FJ, Williams AG, Toms NJ, Tavare JM. Activation of mitogen-activated protein kinase and p70S6 kinase is not correlated with cerebellar granule survival. Biochem J 1997; 324: 365-9
24. 24. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997; 275: 661-665
25. 25. Flier JS, Usher P, Moses AC. Monoclonal antibody to the type 1 insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci 1986; 83: 664-8
26. 26. Bailyes EM, Nave' BT, Soos MA, Orr SR, Hayward AC, Siddle K. Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem J 1997; 327: 209-15
27. 27. Sell C, Rubini M, Rubin R, Liu J-P, Efstratiadis A, Baserga R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor. Proc Natl Acad Sci USA 1993; 90: 11217-21
28. 28. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A, Baserga R. Effect of a null mutation of the type 1 IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 1994; 14: 3604-12
29. 29. Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (igf-1) and type 1 IGF receptor (ifg1r). Cell 1993; 75: 59-72
30. 30. Baker J, Liu J-P, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993; 75: 73-82
31. 31. Miura M, Surmacz E, Burgaud JL, Baserga R. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J Biol Chem 1995; 270: 22639-44
32. 32. Morrione A, Valentinis B, Xu SQ, Yumet G, Louvi A, Efstratiadis A, Baserga R. Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc Natl Acad Sci USA 1997; 94: 3777-82
33. 33. Day ML, Foster RG, Day KC, Zhao X, Hymphrey P, Swanson P, Postigo AA, Zhang SH, Dean DC. Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway. J Biol Chem 1997; 272: 8125-8
34. 34. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619-26
35. 35. Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, Kingsman SM, Kingsman AJ. A transient three-plasmid expression system for the production of higher titer retroviral vectors. Nucleic Acids Res 1995; 23: 628-33
36. 36. Hawley RG, Lieu FH, Fong AZ, Hawley TS. Versatile retroviral vectors for potential use in gene therapy. Gene Therapy 1994; 1: 136-8
37. 37. Coppola D, Ferber A, Miura M, Sell C, D'Ambrosio C, Rubin R, Baserga R. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 1994; 14: 4588-95
38. 38. Miura M, Li S, Baserga R. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells. Cancer Res 1995; 55: 663-7
39. 39. D'Ambrosio C, Keller SR, Morrione A, Lienhard GE, Baserga R, Surmacz E. Transforming potential of the insulin receptor substrate 1. Cell Growth Diff 1995; 6: 557-62
40. 40. Pietrzkowski Z, Lammers R, Carpenter G, Soderquist AM, Limardo M, Phillips PD, Ullrich A, Baserga R. Constitutive expression of insuln-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors. Cell Growth Diff 1992; 3: 199-205
41. 41. Pietrzkowski Z, Sell C, Lammers R, Ullrich A, Baserga R. Roles of insulin-like growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol Cell Biol 1992; 12: 3883-9
42. 42. Pear WS, Nolan GP, Scott ML, Baltimore D. Production of hightiter helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 1993; 90: 8392-6
43. 43. Graham FL, Van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-67
44. 44. Romano G, Guan M, Long WK, Henderson EE. Differential effects on HIV-1 gene regulation by EBV in T lymphocytic and promonocytic cells transduced to express recombinant human CR2 (CD21 ). Virology 1997; 237: 23-32
45. 45. Folkman J, Moscona A. Role of cell shape in growth control. Nature 1978; 273: 345-9
46. 46. Fukazawa H, Mitzuno S, Vehara Y. A microplate assay for quantitation of anchorage-independent growth of transformed cells. Anal Biochem 1995; 228: 83-90
47. 47. Lebowitz PF, Sakamuro D, Prendergast G. Farnesyl transferase inhibitors induce apoptosis of ras-transformed cells denied substratum attachment. Cancer Res 1997; 57: 708-13
48. 48. Valentinis B, Reiss K, Baserga R. IGF-1-mediated survival from anoikis: role of cell aggregation and Focal Adhesion Kinase. J Cell Physiol 1998; in press
49. 49. Webster NJG, Resnik JL, Reichart DB, Strauss B, Haus M, Seely BL. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res 1996; 56: 2781-8
50. 50. Werner H, Karnieli E, Rauscher FJ III, LeRoith D. Wild type and mutant p53 differentially regulate transcription of insulin-like growth factor I receptor gene. Proc Natl Acad Sci 1996; 93: 8318-23
51. 51. Ohlsson C, Kley N, Werner H, LeRoith D. p53 regulates insulin-like growth factor I (IGF-I) receptor expression and IGF-I-in-duced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1. Endocrinology 1998; 139: 1101-7
52. 52. Gronberg M, Wulf BS, Rasmussen JS, Kjeldsen T, Gammeltoft S. Structure function relationship of the insulin-like growth factor-I receptor tyrosine kinase. J Biol Chem 1993; 268: 23435-40
53. 53. Li S, Ferber A, Miura M, Baserga R. Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain. J Biol Chem 1994; 51: 32558-64
54. 54. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kahuria S, Chen E, Jakobs S, Franke U, Ramachandran J, Fujita-Yamaguchi Y. The insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 1986; 5: 2503-12
55. 55. Surmacz E, Sell C, Swantek J, Kato H, Roberts CT Jr, LeRoith D, Baserga R. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor I receptor. Exp Cell Res 1995; 218: 370-80
56. 56. Hongo A, D'Ambrosio C, Miura M, Morrione A, Baserga R. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene 1996; 12: 1231-8
57. 57. Dews M, Nishimoto I, Baserga R. IGF-I receptor protection from apoptosis in cells lacking IRS proteins. Receptors and Signal Transduc 1998; in press
58. 58. Franke TF, Kaplan DR, Cantley LC, Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-biphosphate. Science 1997; 275: 665-8
59. 59. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231-41
60. 60. Del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. Interleukin-3 phosphorylation of BAD through the protein kinase Akt. Science 1997; 278: 687-9
61. 61. Lin TH, Chen Q, Howe A, Juliano HL. Cell anchorage permits efficient signal transduction between ras and its downstream kinases. J Biol Chem 1997; 272: 8849-52
62. 62. Clark S, Eckhardt G, Siddle K, Harrison LC. Changes in insulin-receptor structure associated with trypsin-induced activation of the receptor tyrosine kinase. Biochem J 1991; 276: 27-33
63. 63. Singleton JR, Dixit VM, Feldman EL. Type 1 insulin-like growth factor receptor activation regulates apoptotic proteins. J Biol Chem 1996; 271: 31791-4
64. 64. Guvakova MA, Surmacz E. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp Cell Res 1997; 231: 149-62